UBS AM
AMN icon

UBS AM’s AMN Healthcare AMN Stock Holding History

UBS AM’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Buy
113,340
+18,641
+20% +$354K ﹤0.01% 2025
2025
Q4 		$1.49M Buy
94,699
+3,477
+4% +$62.1K ﹤0.01% 1992
2025
Q3 		$1.77M Sell
91,222
-47,547
-34% -$929K ﹤0.01% 1806
2025
Q2 		$2.87M Buy
138,769
+30,747
+28% +$639K ﹤0.01% 1977
2025
Q1 		$2.64M Buy
108,022
+21,650
+25% +$556K ﹤0.01% 1863
2024
Q4 		$2.07M Sell
86,372
-4,880
-5% -$155K ﹤0.01% 2025
2024
Q3 		$3.87M Sell
91,252
-4,740
-5% -$249K ﹤0.01% 1710
2024
Q2 		$4.92M Buy
95,992
+38,806
+68% +$2.2M ﹤0.01% 1500
2024
Q1 		$3.57M Buy
57,186
+5,101
+10% +$347K ﹤0.01% 1407
2023
Q4 		$3.9M Buy
52,085
+390
+0.8% +$27.9K ﹤0.01% 1366
2023
Q3 		$4.4M Sell
51,695
-4,063
-7% -$385K ﹤0.01% 1263
2023
Q2 		$4.63M Hold
55,758
– – ﹤0.01% 1273
2023
Q1 		$4.63M Buy
+55,758
New +$5.25M ﹤0.01% 1273
2022
Q4 		– Sell
-52,507
Closed -$5.56M – 2555
2022
Q3 		$5.56M Sell
52,507
-11,657
-18% -$1.28M ﹤0.01% 1162
2022
Q2 		$7.04M Buy
64,164
+3,080
+5% +$305K ﹤0.01% 1090
2022
Q1 		$6.37M Buy
61,084
+870
+1% +$90.3K ﹤0.01% 1255
2021
Q4 		$7.37M Sell
60,214
-3,679
-6% -$408K ﹤0.01% 1241
2021
Q3 		$7.33M Sell
63,893
-1,497
-2% -$159K ﹤0.01% 1210
2021
Q2 		$6.34M Buy
65,390
+9,172
+16% +$796K ﹤0.01% 1272
2021
Q1 		$4.14M Buy
56,218
+144
+0.3% +$10.7K ﹤0.01% 1420
2020
Q4 		$3.83M Buy
56,074
+3,133
+6% +$204K ﹤0.01% 1404
2020
Q3 		$3.09M Sell
52,941
-1,153
-2% -$60.7K ﹤0.01% 1353
2020
Q2 		$2.45M Buy
54,094
+632
+1% +$30.2K ﹤0.01% 1440
2020
Q1 		$3.09M Sell
53,462
-267
-0.5% -$18.3K ﹤0.01% 1243
2019
Q4 		$3.35M Sell
53,729
-88,631
-62% -$5.24M ﹤0.01% 1370
2019
Q3 		$8.19M Buy
142,360
+15,828
+13% +$876K 0.01% 1027
2019
Q2 		$6.86M Buy
126,532
+25,692
+25% +$1.3M ﹤0.01% 1087
2019
Q1 		$4.75M Sell
100,840
-11,641
-10% -$645K ﹤0.01% 1167
2018
Q4 		$6.37M Buy
112,481
+34,276
+44% +$1.92M 0.01% 1005
2018
Q3 		$4.28M Buy
78,205
+1,495
+2% +$85.6K ﹤0.01% 1200
2018
Q2 		$4.5M Sell
76,710
-814
-1% -$48.6K ﹤0.01% 1193
2018
Q1 		$4.4M Buy
77,524
+44,699
+136% +$2.43M ﹤0.01% 1191
2017
Q4 		$1.62M Buy
32,825
+2,078
+7% +$94.7K ﹤0.01% 1531
2017
Q3 		$1.41M Buy
30,747
+665
+2% +$25.4K ﹤0.01% 1549
2017
Q2 		$1.17M Sell
30,082
-2,133
-7% -$81.8K ﹤0.01% 1587
2017
Q1 		$1.31M Buy
32,215
+13,957
+76% +$547K ﹤0.01% 1528
2016
Q4 		$702K Sell
18,258
-8,340
-31% -$285K ﹤0.01% 1701
2016
Q3 		$848K Sell
26,598
-4,460
-14% -$169K ﹤0.01% 1748
2016
Q2 		$1.24M Buy
31,058
+5,860
+23% +$217K ﹤0.01% 1550
2016
Q1 		$847K Sell
25,198
-8,217
-25% -$235K ﹤0.01% 1704
2015
Q4 		$1.04M Hold
33,415
– – ﹤0.01% 1730
2015
Q3 		$1M Buy
33,415
+9,800
+41% +$323K ﹤0.01% 1721
2015
Q2 		$746K Buy
23,615
+1,300
+6% +$34K ﹤0.01% 1833
2015
Q1 		$515K Buy
22,315
+1,200
+6% +$24.8K ﹤0.01% 1967
2014
Q4 		$414K Buy
21,115
+2,200
+12% +$37.8K ﹤0.01% 2045
2014
Q3 		$297K Hold
18,915
– – ﹤0.01% 2151
2014
Q2 		$233K Hold
18,915
– – ﹤0.01% 2329
2014
Q1 		$260K Hold
18,915
– – ﹤0.01% 2272
2013
Q4 		$278K Sell
18,915
-1,100
-5% -$14.9K ﹤0.01% 2186
2013
Q3 		$275K Hold
20,015
– – ﹤0.01% 2136
2013
Q2 		$287K Buy
+20,015
New +$281K ﹤0.01% 2016

Other funds holding AMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS AM's AMN Position: Q1 2026 in Review

UBS AM increased its AMN Healthcare (AMN) stake by 20% in Q1 2026, buying an estimated $354K and bringing the position to 113,340 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

UBS AM first reported a position in AMN in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.19M in Q3 2019. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • UBS AM held 113,340 shares of AMN Healthcare worth $2.08M as of Q1 2026.
  • UBS AM bought 18,641 AMN Healthcare shares in Q1 2026, an estimated $354K.
  • AMN Healthcare made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2025 holding.
  • UBS AM first reported a position in AMN Healthcare in Q2 2013 and has held it in 51 quarters since.
  • UBS AM's AMN Healthcare position peaked at $8.19M in Q3 2019.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.